It is not objectively good news, but Rocket Lab found a defect before risking catastrophic failure on the launchpad.

Rocket Lab heads into its third-quarter report with a striking disconnect. The business keeps setting records, the backlog keeps climbing, and management sounded more expansive last quarter than at ...

Rocket Lab's valuation is heavily dependent on unproven future projects, increasing risk for current shareholders. Read why ...

Rocket Lab is keeping us waiting for Neutron.

Rocket Lab’s reported decline from $151 in May to $54.73 on October 30 raises questions about the valuation of its expanding ...

Could two numbers in the space company's next report make its 61% drop a buying opportunity?

Rocket Lab Corporation remains a buy despite an expected nearly one-year Neutron rocket delay and increased perceived risk.

Rocket Lab's Neutron rocket just slipped past a key deadline, and Wall Street is starting to reprice how long investors will wait for the launch revenue that underpins the entire bull case.

Rocket Lab has posted big revenue growth, but its stock has still seen a huge pullback.

Rocket Lab’s updated analyst models show a small trim in fair value, with the price target shifting from about US$105.05 to ...

Rocket Lab delays the Neutron rocket's first launch to 2027 after carbon fiber tank dome defects, highlighting manufacturing ...